Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Supplement Hearing Spotlights Self-Regulation, FDA Enforcement

This article was originally published in The Tan Sheet

Executive Summary

A Government Accountability Office investigation intended to shed light on whether senior citizens are at risk when buying herbal supplements has refueled debate on the effectiveness of both FDA enforcement and industry self-regulation

You may also be interested in...



'Potentially Harmful' Supplements Evade FDA, Baffle Retailers – Consumer Reports

Consumer Reports criticizes FDA current regulation of the dietary supplement industry, saying it found 15 supplement ingredients that are “potentially harmful” and can cause organ damage, cancer and "possibly death."

U.K. Supplement Retailer’s “Suitable” Customer Advice Likely Unsuitable In U.S.

Holland & Barrett ads clarify store clerks’ advice “would be in relation to nutrition and supplements, rather than general or individual health advice,” the UK advertising regulator says. While some US retailers train staff about supplement claims, they do not have as much room for advising customers as the UK agency allows in its ruling on a challenge.

U.K. Supplement Retailer’s “Suitable” Customer Advice Likely Unsuitable In U.S.

Holland & Barrett ads clarify store clerks’ advice “would be in relation to nutrition and supplements, rather than general or individual health advice,” the UK advertising regulator says. While some US retailers train staff about supplement claims, they do not have as much room for advising customers as the UK agency allows in its ruling on a challenge.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104166

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel